What is the Bristol Stool Scale?

The Bristol Stool Form Scale (BSS) is a standardized 7-type visual classification system for human stool form, developed by Heaton and Lewis at the University of Bristol in 1997. It is the internationally accepted clinical standard for documenting stool consistency and correlates directly with gastrointestinal transit time.

What is the normal stool type on the Bristol scale?

Types 3 and 4 are considered normal stool form for most adults. Type 4 (smooth, soft sausage) represents the ideal transit time of approximately 40 hours. Type 3 (sausage with surface cracks) is also normal. Types 1–2 indicate slower transit (constipation tendency); types 5–7 indicate faster transit (diarrhea tendency).

What stool type indicates constipation on the Bristol scale?

Bristol types 1 and 2 indicate constipation: Type 1 (separate hard lumps) represents very slow transit (~100 hours) and severe constipation. Type 2 (sausage-shaped but lumpy) also indicates constipation. These types are used in Rome IV criteria for IBS-C: types 1–2 in more than 25% of stools.

What stool type indicates diarrhea on the Bristol scale?

Bristol types 6 and 7 indicate diarrhea: Type 6 (fluffy pieces with ragged edges) indicates fast transit. Type 7 (watery, no solid pieces) indicates very rapid transit (~10 hours) or secretory/osmotic diarrhea. Rome IV IBS-D criteria require types 6–7 in more than 25% of stools.

How is the Bristol Stool Scale used for IBS classification?

Rome IV IBS diagnostic criteria use Bristol types for subtype classification: IBS-C (constipation-predominant) = types 1–2 in more than 25% AND types 6–7 in less than 25%. IBS-D (diarrhea-predominant) = types 6–7 in more than 25% AND types 1–2 in less than 25%. IBS-M (mixed) = types 1–2 AND types 6–7 both more than 25%.

How do I use the Bristol Stool Scale to improve bowel health?

Track your stool type for 1–2 weeks to identify your predominant pattern. If consistently types 1–2: increase dietary fiber (25–38 g/day), increase fluid intake (8–10 cups/day), and increase physical activity. If consistently types 6–7: reduce trigger foods, consider soluble fiber (psyllium), and consult your provider about underlying causes.

Does the Bristol Stool Scale measure transit time?

Indirectly, yes. The BSS was validated against radiopaque marker transit studies. Approximate transit times: Type 1 = 100 hours (very slow). Type 4 = 40 hours (normal). Type 7 = 10 hours (very fast). This correlation allows BSS to serve as a practical indirect transit time measure without formal radiopaque marker studies.

How is the Bristol Stool Scale used in IBD monitoring?

In inflammatory bowel disease (IBD — Crohn's disease and ulcerative colitis), BSS tracks stool consistency to monitor disease activity and treatment response. During active disease, stools are typically types 6–7 with increased frequency. During remission, types return toward 3–4. BSS is combined with stool frequency, rectal bleeding (MAYO score), and calprotectin for comprehensive IBD monitoring.

What is the Bristol Stool Scale for children?

The standard adult Bristol Stool Scale is not validated for young children, particularly infants. Breastfed infants normally produce soft, mushy stools (types 5–6) that would indicate diarrhea in adults. For children, the Amsterdam stool scale or modified pediatric stool consistency tools are more appropriate. Consult a pediatrician or pediatric gastroenterologist for stool concerns in young children.

Can loperamide or laxatives change my Bristol stool type?

Yes. Loperamide (anti-diarrheal) slows transit and shifts stool type from 6–7 toward 3–4 in diarrheal conditions. Osmotic laxatives (PEG 3350/MiraLax) increase water retention in the colon, shifting type from 1–2 toward 3–4. The BSS is an ideal tool for monitoring medication effects on stool consistency.

What is a normal frequency of bowel movements alongside Bristol type?

Normal bowel movement frequency ranges from 3 times per day to 3 times per week, with stool type 3–4. Frequency below 3 per week combined with types 1–2 suggests constipation. Frequency above 3 per day combined with types 6–7 suggests diarrhea. Both frequency and consistency (Bristol type) should be evaluated together for complete bowel habit assessment.

Online Medical Tools — Bristol Stool Scale

Printed on 9/3/2026

For informational purposes only. This is not medical advice.

Gastroenterology

Bristol Stool Scale

The Bristol Stool Scale is a standardized 7-type visual stool form classification commonly used in gastroenterology and primary care. It helps describe bowel habit patterns consistently over time and supports communication between patients and clinicians.

Formula: Ordinal stool-form classification from Type 1 (hard) to Type 7 (watery).

Bristol Stool Type

Save your results with a free account

Keep a history of calculations, favorite tools, and access your dashboard anytime.

Create free account Sign in

How It Works

Identify stool type from 7 illustrated categories

Patient identifies their stool type from 7 standardized categories: Type 1 (separate hard lumps like nuts), Type 2 (sausage-shaped but lumpy), Type 3 (sausage with surface cracks), Type 4 (smooth soft sausage), Type 5 (soft blobs with clear-cut edges), Type 6 (fluffy pieces with ragged edges), Type 7 (watery, no solid pieces).

Interpret transit time and bowel habit pattern

Types 3–4 = normal transit (approximately 40 hours). Types 1–2 = slow transit/constipation (approximately 100 hours). Types 5–7 = fast transit/diarrhea (approximately 10 hours). Use this to characterize bowel habit patterns and monitor treatment response.

Apply to diagnostic criteria and clinical decisions

Use Bristol stool type to qualify for IBS diagnostic criteria (Rome IV): IBS-C requires types 1–2 in more than 25% of stools; IBS-D requires types 6–7 in more than 25% of stools. Track changes over time to assess treatment efficacy.

Who Uses the Bristol Stool Scale

IBS Classification Per Rome IV Criteria

Gastroenterologists

Apply Bristol Stool Scale to classify IBS subtypes per Rome IV: IBS-C (types 1–2 predominant), IBS-D (types 6–7 predominant), IBS-M (mixed), and IBS-U (unclassified). The BSS is embedded in the official Rome IV diagnostic criteria.

Constipation Treatment Monitoring

Gastroenterologists

Track Bristol stool type change in response to fiber supplementation, osmotic laxatives (PEG 3350), stimulant laxatives, or prescription agents (lubiprostone, linaclotide). Target shift from types 1–2 toward types 3–4.

Inflammatory Bowel Disease Stool Consistency Tracking

IBD nurses

Monitor stool consistency in Crohn's disease and ulcerative colitis patients to track disease activity, treatment response, and distinguish IBD flare from IBS-like functional symptoms during remission.

Dietary Intervention Response Assessment

Dietitians

Assess changes in stool form following dietary modifications — increased fiber, FODMAP diet, probiotic supplementation, or hydration changes. Bristol type provides an objective patient-reported outcome measure.

Clinical Trial GI Endpoint Measurement

Researchers

Use as a validated patient-reported outcome (PRO) endpoint in clinical trials for constipation, diarrhea, IBS, and IBD treatments. The FDA PRO Guidance (2009) endorses the Bristol Stool Scale for GI clinical trials.

Pro Tips

BSS correlates with GI transit time — the clinical gold standard

The Bristol Stool Form Scale is the internationally accepted standard for stool form documentation because it directly correlates with whole gut transit time: Type 1 ≈ 100 hours, Type 4 ≈ 40 hours, Type 7 ≈ 10 hours (Heaton and Lewis, 1997). It is more practical than radiopaque marker transit studies for routine clinical use.

Rome IV embeds BSS in IBS diagnostic criteria

IBS Rome IV subtype classification explicitly uses Bristol types: IBS-C requires types 1–2 in more than 25% of stools (with types 6–7 in less than 25%). IBS-D requires types 6–7 in more than 25% (with types 1–2 in less than 25%). Correct BSS documentation is essential for accurate IBS subtype classification.

Visual aids improve accuracy — verbal description alone is unreliable

Inter-observer reliability of the BSS improves significantly when patients use visual illustrated aids rather than verbal descriptions alone. Digital or laminated BSS cards improve accuracy. When providing the scale verbally without visuals, reliability decreases.

Fiber and hydration target: types 3–4 consistently

The dietary management goal for both constipation and diarrhea is producing types 3–4 consistently. For constipation: increase fiber (target 25–38 g/day) and fluid intake. For diarrhea: reduce insoluble fiber, increase soluble fiber (psyllium, oat bran). Adequate hydration is essential — 8–10 cups/day minimum.

Red flags alongside type 6–7 require urgent evaluation

Persistent loose stools (types 6–7) with red flag symptoms warrant urgent evaluation to exclude organic pathology: rectal bleeding, unintentional weight loss (>5 kg in 6 months), nocturnal symptoms, family history of colorectal cancer (CRC) or IBD, age above 50 with new onset, or iron deficiency anemia.

Loperamide shifts IBS-D stools toward types 3–4

Loperamide (Imodium) reduces stool frequency and shifts Bristol type from 6–7 toward 3–4 in IBS-D. It is effective for diarrhea symptom control but does not address abdominal pain. For IBS-D with pain, combination therapy (low-dose antidepressant or rifaximin) may be needed.

PEG 3350 for constipation shifts types 1–2 toward types 3–4

Polyethylene glycol 3350 (MiraLax, Movicol) is first-line osmotic laxative for functional constipation. It consistently shifts Bristol type from 1–2 toward 3–4 within 1–3 days. Evidence: Ford et al. (Cochrane 2011) — PEG superior to lactulose for stool consistency and frequency.

Fecal calprotectin helps distinguish IBS from IBD in persistent type 6–7

When patients have persistent type 6–7 stools, fecal calprotectin (normal: below 50 mcg/g) is a cost-effective first-line test to distinguish IBS (normal calprotectin) from IBD (elevated calprotectin, typically above 200 mcg/g). A normal calprotectin has high negative predictive value for IBD.

Pediatric BSS norms differ from adults

Children, especially infants and toddlers, have different normal stool patterns. Breastfed infants commonly produce very soft (type 5–6) stools. Standard adult BSS norms do not apply to pediatric patients. Use pediatric-specific reference ranges and the Amsterdam stool scale for young children.

Common Questions About Your Results

Evidence-Based Methodology

Bristol Stool Form Scale published by Heaton and Lewis (Scand J Gastroenterol 1997). Validated correlation with whole gut transit time: Type 1 = 100h, Type 4 = 40h, Type 7 = 10h. Intra-observer reliability kappa 0.71. IBS Rome IV criteria (Lacy et al., Gastroenterology 2016) reference Bristol types 1–2 for IBS-C and 6–7 for IBS-D. BSS in clinical trials: FDA PRO Guidance (2009) endorses BSS for patient-reported outcomes. Global prevalence of IBS: Sperber et al. (Gastroenterology 2021) — 4.1% using Rome IV criteria.

Clinical Content Trust

Last reviewed:: April 21, 2026
Guideline version:: General evidence framework v2026.04
Source set version:: Primary-source set v1

How to Interpret Your Result

Lower stool types suggest harder stool and slower transit; higher types indicate looser stool and faster transit.

When to Use This Tool

Use this tool for bowel symptom tracking in constipation, IBS, diarrhea evaluation, and treatment follow-up conversations.

Limitations

The Bristol scale describes form, not etiology. Diagnosis still requires broader history, alarm-feature screening, and targeted testing when needed.

For related assessments, see Rockall Score, AIMS65 and Water Intake.

Disclaimer: This tool is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about your health.

Changelog

April 21, 2026 · trust-baseline
Clinical trust metadata enabled for this tool page with structured review/version fields.

Related Tools